Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.5B bought by 347 insiders at 211 companies
- $3.3B sold by 273 insiders outside a trading plan
- $7.9B sold by 829 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month, each insider's filings added up.
-
LENLennarBerkshire Hathaway Inc.10% owner, +1 joint filer$383M
-
CRBGCorebridge FinancialLife Insurance Co Nippon10% owner$225M
-
KODKodiak SciencesBaker Bros. Advisors LPDirector, +5 joint filers$157M
-
SAFXXCF GlobalEEME Energy SPV I, LLC10% owner$142M
-
GPIGroup 1 AutomotiveConifer Management, L.L.C.10% owner$97.8M
-
UUUUniversal Safety ProductsMilton C Ault IIIDirector$92.5M
-
GMEGameStopRyan CohenCEO$50.4M
-
BORRBorr DrillingTor Olav TroimDirector$43M
-
PAMPampa EnergiaMarcos Marcelo MindlinDirector$35.1M
-
GGRGogoroChung-Yao YinDirector$35.1M
Biggest sales
Past month, each insider's filings added up. Planned sales are marked.
-
IHTInnSuites Hospitality TrustJames F WirthCEO$4.2B
-
MDLNMedlineGIC Private Ltd10% owner, +2 joint filers$996M
-
ESTCElasticSteven SchuurmanDirector$323M
-
TALOTalos EnergyEmpresarial De Capitales S.a. De C.v. Control10% owner$253M
-
AVGOBroadcomHenry SamueliDirector$250M
-
THTarget HospitalityTDR Capital II Investments LP10% owner, +9 joint filers$202M
-
ANETArista NetworksJayshree UllalCEO$166M
-
KNTKKinetikISQ Global Fund II GP LLC10% owner, +4 joint filers$134M
-
CRWDCrowdStrikeBurt W. PodbereCFO$125M
-
NBISNebius GroupOphir NaveCOO$118M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days, most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more
-
Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
VOR insider trades
Every open-market buy and sale in VOR, one row per filing, newest first
-
Ra Capital Management, L.P. 10% owner, +3 joint filersVORVor BiopharmaSale$4,207 213 shares at $19.75 <0.1% of stakeTraded Jul 16 Filed Jul 21
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$2.6M 165,150 shares at $15.77 6.4% of stakeTraded Apr 22 Filed Apr 24
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$10.2M 630,374 shares at $16.14 20% of stakeTraded Apr 17–20 Filed Apr 21
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$11.9M 737,989 shares at $16.10 19% of stakeTraded Apr 13–15 Filed Apr 15
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$10.2M 620,133 shares at $16.50 14% of stakeTraded Apr 8–10 Filed Apr 10
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$14.5M 849,257 shares at $17.10 16% of stakeTraded Apr 2–6 Filed Apr 6
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$10.4M 400,408 shares at $25.90 34% of stakeTraded Oct 28–30 Filed Oct 30, 2025
-
Ra Capital Management, L.P. Director, +3 joint filersVORVor BiopharmaSale$6.2M 221,166 shares at $28.06 16% of stakeTraded Oct 23–27 Filed Oct 27, 2025
-
Ra Capital Management, L.P. Director, +4 joint filersVORVor BiopharmaSale$3.4M 117,050 shares at $29.34 7.7% of stakeTraded Oct 20–21 Filed Oct 22, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerVORVor BiopharmaSale$1.1M 37,533 shares at $30.19 3.1% of stakeTraded Oct 17–21 Filed Oct 21, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerVORVor BiopharmaSale$2.3M 73,676 shares at $31.88 5.8% of stakeTraded Oct 15–16 Filed Oct 17, 2025
-
Ra Capital Management, L.P. Director, +4 joint filersVORVor BiopharmaSale$13.7M 464,025 shares at $29.54 97% of stakeTraded Oct 15–17 Filed Oct 17, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerVORVor BiopharmaSale$3M 96,657 shares at $31.08 7% of stakeTraded Oct 10–14 Filed Oct 15, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerVORVor BiopharmaSale$4.1M 124,146 shares at $33.16 8.3% of stakeTraded Oct 8–9 Filed Oct 10, 2025
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.